Vogenx, Inc.
VOGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001903784
No open-market purchases or sales by Vogenx, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of VOGX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vogenx, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13G | 13.00%1.92M shares | New | Sep 8, 20261 filing | Sep 8, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Vogenx, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 202611:50 AM ET | Janus Henderson Group PLC | 13G | 13.00%1.92M shares | New | Aug 31, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Vogenx, Inc. shares.
No Form 144 notices for Vogenx, Inc. are on file.